Acetylator status and its relationship to breast cancer and other diseases of the breast
- 1 November 1987
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 23 (11) , 1701-1706
- https://doi.org/10.1016/0277-5379(87)90453-6
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Dietary Fat and the Risk of Breast CancerNew England Journal of Medicine, 1987
- Blood group as a prognostic indicator in breast cancer.BMJ, 1985
- A rapid method for determination of acetylation phenotype using dapsone.British Journal of Clinical Pharmacology, 1984
- ROLE OF N-ACETYLTRANSFERASE PHENOTYPES IN BLADDER CARCINOGENESIS: A PHARMACOGENETIC EPIDEMIOLOGICAL APPROACH TO BLADDER CANCERThe Lancet, 1982
- Acetylator phenotyping: A comparison of the isoniazid and dapsone testsEuropean Journal of Clinical Pharmacology, 1981
- Acetylator Phenotype in Patients with Breast CancerOncology, 1978
- Clinical consequences of polymorphic acetylation of basic drugsClinical Pharmacology & Therapeutics, 1977
- RAUWOLFIA DERIVATIVES AND BREAST CANCER IN HYPERTENSIVE WOMENThe Lancet, 1976
- Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practicesInternational Journal of Cancer, 1975
- Changing Incidence of Breast Cancer in Japanese-American Women2JNCI Journal of the National Cancer Institute, 1973